8-K: Ingevity to Close Crossett Plant, Announces Restructuring for Improved Profitability

Ingevity Corporation will close its Crossett, Arkansas plant and consolidate operations to its North Charleston facility, aiming for significant cost savings and improved profitability in its Performance Chemicals segment.

Summary

• Ingevity is closing its Crossett, Arkansas manufacturing plant in August 2024 as part of a strategic repositioning of its Performance Chemicals segment.
• The company will transition the refining of oleo-based products from the Crossett plant to its North Charleston, South Carolina facility.
• This consolidation is expected to generate annual operational savings of approximately $20 million to $25 million starting in 2025.
• Ingevity also announced corporate and business-related cost reduction actions that are expected to yield an additional $10 million in annual savings beginning in 2025.
• The company anticipates incurring aggregate charges of approximately $100 million due to these actions, including $65 million in non-cash asset-related charges, $10 million in severance and other employee-related costs, and $25 million in other restructuring costs.
• The majority of non-cash charges and 50-60% of cash charges are expected to be recognized by the first half of 2025.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the expected cost savings and improved profitability, but it is tempered by the significant restructuring charges and the impact on employees.

Positives

• The consolidation of operations is expected to result in significant annual cost savings of $20 million to $25 million from the Crossett plant closure.
• Additional cost reduction actions are expected to yield $10 million in annual savings.
• The move is intended to improve the profitability of the Performance Chemicals segment.
• The North Charleston facility has the capacity to expand to meet future market growth.
• The company is streamlining its manufacturing footprint by consolidating oleo-based and crude tall oil-based chemical refinery operations at one facility.

Negatives

• The closure of the Crossett plant will result in approximately $100 million in charges, including $65 million in non-cash asset-related charges.
• The company will incur $10 million in severance and other employee-related costs.
• There will be $25 million in other restructuring costs, including decommissioning and contract termination costs.
• The majority of non-cash charges and 50-60% of cash charges are expected to be recognized by the first half of 2025.
• The closure of the Crossett plant will impact employees and the surrounding community.

Risks

• The actual charges and savings may differ materially from the current estimates due to various assumptions and risks.
• The company may incur other material charges not currently contemplated.
• The pace of growth in oleo markets has been impacted by a slow industrial recovery.
• There are risks associated with the transition of operations and potential disruptions.
• The company faces risks related to global economic conditions, competition, and supply chain disruptions.

Future Outlook

Ingevity expects to realize the full benefit of the cost savings beginning in 2025 and will continue to evaluate strategic options to maximize the profitability of its Performance Chemicals segment.

Management Comments

• Ingevity president and CEO, John Fortson, stated that the announcement is another positive step toward maximizing the profitability of the Performance Chemicals segment.
• Rich White, Ingevity senior vice president and president, Performance Chemicals, noted that the North Charleston facility has the capability to meet current customer demand and supply new business.

Industry Context

This announcement reflects a trend in the chemical industry towards optimizing manufacturing footprints and reducing costs to improve profitability, particularly in response to market conditions and slow industrial recovery.

Comparison to Industry Standards

• The consolidation of manufacturing operations is a common strategy in the chemical industry to improve efficiency and reduce costs, similar to actions taken by companies like Dow and BASF in recent years.
• The expected cost savings of $20-25 million from the plant closure are significant and align with industry benchmarks for restructuring initiatives.
• The charges of $100 million are substantial but not uncommon for companies undergoing significant restructuring, similar to charges incurred by DuPont during its restructuring efforts.
• The move to consolidate operations at a single site is similar to strategies employed by companies like Eastman Chemical to streamline their manufacturing processes.

Stakeholder Impact

• Shareholders are expected to benefit from improved profitability and cost savings.
• Employees at the Crossett plant will be impacted by the closure, with severance and other employee-related costs being incurred.
• The surrounding community of the Crossett plant will be affected by the plant closure.
• Customers are not expected to be impacted by the transition of operations.

Next Steps

• Ingevity will continue to evaluate options for the Crossett site.
• The company will provide additional detail during its second quarter 2024 earnings webcast and conference call on August 1, 2024.
• Ingevity will continue to assess various strategic options to maximize the profitability of its Performance Chemicals segment.

Key Dates

Keywords

Ingevity, Performance Chemicals, Crossett Plant, Plant Closure, Restructuring, Cost Reduction, Oleo-based Products, Manufacturing Consolidation, Profitability, Operational Savings